As a pivotal signaling pathway of osteoclastic differentiation and function, RANKL-mediated NFATc1 activation has emerged as a novel target for the treatment of osteoporosis (Vihma et al., 2008; Zhao et al., 2010). The gene discussed is TNFSF11; the disease is osteoporosis.